Literature DB >> 16829135

Expression, purification and characterization of factor IX derivatives using a novel vector system.

Likui Yang1, Kota Gopalakrishna, Chandrashekhara Manithody, Alireza R Rezaie.   

Abstract

Recent studies have indicated that the loop harboring the S1 specificity site (residues 185-189 in chymotrypsin numbering) of coagulation proteases has several charged residues with important structural and functional roles for the catalytic activity of these proteases. This loop is allosterically linked to the Na(+)-binding site in both factor Xa and thrombin. There are three candidate residues (His-185, Glu-186, and Arg-188) on this loop of factor IXa (fIXa) whose side chains can influence the Na(+) binding and the catalytic function of the protease in the intrinsic Xase complex. In this study, we developed a novel expression/purification vector system, substituted all three residues of factor IX individually with Ala, and expressed the mutant zymogens in mammalian cells. Following activation, all three fIXa mutants exhibited normal activity towards a fIXa-specific chromogenic substrate in the presence of Ca(2+) with no obvious requirement for Na(+) in the reaction. Furthermore, all three mutants interacted with factor VIIIa with near normal affinity and catalyzed the activation of factor X in the intrinsic Xase complex with a normal catalytic efficiency. These results suggest that, unlike thrombin and factor Xa, the charged residues of this loop do not play a functional role in modulating the catalytic function of fIXa in the intrinsic Xase complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16829135     DOI: 10.1016/j.pep.2006.05.012

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

2.  Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.

Authors:  Shabir H Qureshi; Likui Yang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2012-09-26       Impact factor: 5.249

3.  Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.

Authors:  Qiuya Lu; Likui Yang; Chandrashekhara Manithody; Xuefeng Wang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2015-06-10       Impact factor: 3.162

4.  Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.

Authors:  Kanagasabai Vadivel; Herman A Schreuder; Alexander Liesum; Amy E Schmidt; Gunaseelan Goldsmith; S Paul Bajaj
Journal:  J Thromb Haemost       Date:  2019-03-06       Impact factor: 5.824

5.  Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.

Authors:  Likui Yang; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.